We are developing vamorolone (VBP15) as a dissociative GR ligand and have previously reported that it shows efficacy similar to prednisone in the mdx mouse model of DMD, in the absence of traditional steroid side effects in the mdx mouse (23). This evidence concerns the gene NR3C1 and Duchenne muscular dystrophy.